Christian S. Schade has joined NRG Energy Inc. as executive vice president and will assume the position of chief financial officer (CFO) in early May.
Most recently, Schade was senior vice president and CFO at Medarex, a Princeton, N.J.-based biopharmaceutical company acquired by Bristol-Myers Squibb Co.
Prior to Bristol-Myers Squibb, Schade was a managing director in the debt capital markets group at Merrill Lynch & Co., where he oversaw public and private capital-markets transactions for corporate clients throughout Europe, Africa and the Middle East. Previously, he served in various corporate finance and capital market positions in New York and London for both Merrill Lynch and J.P. Morgan.
Gerald Luterman, in addition to continuing his board of director responsibilities on the finance committee, has served as NRG's interim CFO since November 2009. He will remain as CFO until early May and then expects to resume his role as an independent director and member of the NRG board of directors' audit committee.
SOURCE: NRG Energy Inc. Â
